Logo image of CRNC

CERENCE INC (CRNC) Stock Fundamental Analysis

NASDAQ:CRNC - Nasdaq - US1567271093 - Common Stock - Currency: USD

8.55  -0.01 (-0.12%)

After market: 8.5633 +0.01 (+0.16%)

Fundamental Rating

3

CRNC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. CRNC has a bad profitability rating. Also its financial health evaluation is rather negative. CRNC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRNC had positive earnings in the past year.
In the past year CRNC had a positive cash flow from operations.
In the past 5 years CRNC reported 4 times negative net income.
CRNC had a positive operating cash flow in 4 of the past 5 years.
CRNC Yearly Net Income VS EBIT VS OCF VS FCFCRNC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

CRNC has a Return On Assets of -50.57%. This is amonst the worse of the industry: CRNC underperforms 84.40% of its industry peers.
CRNC's Return On Equity of -225.49% is on the low side compared to the rest of the industry. CRNC is outperformed by 81.91% of its industry peers.
CRNC's Return On Invested Capital of 1.41% is fine compared to the rest of the industry. CRNC outperforms 68.44% of its industry peers.
Industry RankSector Rank
ROA -50.57%
ROE -225.49%
ROIC 1.41%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
CRNC Yearly ROA, ROE, ROICCRNC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

CRNC's Operating Margin of 3.57% is fine compared to the rest of the industry. CRNC outperforms 69.50% of its industry peers.
In the last couple of years the Operating Margin of CRNC has grown nicely.
Looking at the Gross Margin, with a value of 70.24%, CRNC is in line with its industry, outperforming 53.55% of the companies in the same industry.
CRNC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.57%
PM (TTM) N/A
GM 70.24%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
CRNC Yearly Profit, Operating, Gross MarginsCRNC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRNC is destroying value.
CRNC has more shares outstanding than it did 1 year ago.
CRNC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRNC is higher compared to a year ago.
CRNC Yearly Shares OutstandingCRNC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRNC Yearly Total Debt VS Total AssetsCRNC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.95, we must say that CRNC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRNC (-0.95) is worse than 74.47% of its industry peers.
The Debt to FCF ratio of CRNC is 6.83, which is on the high side as it means it would take CRNC, 6.83 years of fcf income to pay off all of its debts.
CRNC has a Debt to FCF ratio of 6.83. This is comparable to the rest of the industry: CRNC outperforms 53.55% of its industry peers.
CRNC has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
CRNC has a worse Debt to Equity ratio (1.32) than 78.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.83
Altman-Z -0.95
ROIC/WACC0.16
WACC8.62%
CRNC Yearly LT Debt VS Equity VS FCFCRNC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CRNC has a Current Ratio of 1.47. This is a normal value and indicates that CRNC is financially healthy and should not expect problems in meeting its short term obligations.
CRNC's Current ratio of 1.47 is in line compared to the rest of the industry. CRNC outperforms 48.23% of its industry peers.
A Quick Ratio of 1.46 indicates that CRNC should not have too much problems paying its short term obligations.
CRNC has a Quick ratio (1.46) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.46
CRNC Yearly Current Assets VS Current LiabilitesCRNC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The earnings per share for CRNC have decreased strongly by -38.89% in the last year.
CRNC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.41% yearly.
CRNC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.06%.
The Revenue has been growing slightly by 1.79% on average over the past years.
EPS 1Y (TTM)-38.89%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%733.33%
Revenue 1Y (TTM)-27.06%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%15.02%

3.2 Future

Based on estimates for the next years, CRNC will show a very strong growth in Earnings Per Share. The EPS will grow by 26.55% on average per year.
Based on estimates for the next years, CRNC will show a decrease in Revenue. The Revenue will decrease by -4.80% on average per year.
EPS Next Y-69.13%
EPS Next 2Y-44.6%
EPS Next 3Y-29.21%
EPS Next 5Y26.55%
Revenue Next Year-25.61%
Revenue Next 2Y-10.65%
Revenue Next 3Y-4.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRNC Yearly Revenue VS EstimatesCRNC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CRNC Yearly EPS VS EstimatesCRNC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.95 indicates a correct valuation of CRNC.
87.23% of the companies in the same industry are more expensive than CRNC, based on the Price/Earnings ratio.
CRNC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
With a Price/Forward Earnings ratio of 24.23, CRNC is valued on the expensive side.
CRNC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CRNC is cheaper than 70.57% of the companies in the same industry.
CRNC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.95
Fwd PE 24.23
CRNC Price Earnings VS Forward Price EarningsCRNC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

77.31% of the companies in the same industry are more expensive than CRNC, based on the Enterprise Value to EBITDA ratio.
CRNC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRNC is cheaper than 94.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.79
EV/EBITDA 24.84
CRNC Per share dataCRNC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

CRNC's earnings are expected to decrease with -29.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-44.6%
EPS Next 3Y-29.21%

0

5. Dividend

5.1 Amount

CRNC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CERENCE INC

NASDAQ:CRNC (8/5/2025, 8:06:38 PM)

After market: 8.5633 +0.01 (+0.16%)

8.55

-0.01 (-0.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners77.43%
Inst Owner Change-0.07%
Ins Owners5.47%
Ins Owner Change1.66%
Market Cap369.87M
Analysts72.31
Price Target11.83 (38.36%)
Short Float %22.53%
Short Ratio5.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)86.78%
Min EPS beat(2)84.96%
Max EPS beat(2)88.61%
EPS beat(4)4
Avg EPS beat(4)140.56%
Min EPS beat(4)81.16%
Max EPS beat(4)307.51%
EPS beat(8)7
Avg EPS beat(8)84.53%
EPS beat(12)10
Avg EPS beat(12)89.28%
EPS beat(16)13
Avg EPS beat(16)69.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)1.42%
Revenue beat(4)3
Avg Revenue beat(4)3.33%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)12.76%
Revenue beat(8)6
Avg Revenue beat(8)3.91%
Revenue beat(12)9
Avg Revenue beat(12)3.08%
Revenue beat(16)9
Avg Revenue beat(16)2.01%
PT rev (1m)3.88%
PT rev (3m)0.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.02%
EPS NY rev (1m)1.61%
EPS NY rev (3m)151.39%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-6.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.77%
Valuation
Industry RankSector Rank
PE 12.95
Fwd PE 24.23
P/S 1.45
P/FCF 9.79
P/OCF 8.47
P/B 2.48
P/tB N/A
EV/EBITDA 24.84
EPS(TTM)0.66
EY7.72%
EPS(NY)0.35
Fwd EY4.13%
FCF(TTM)0.87
FCFY10.21%
OCF(TTM)1.01
OCFY11.81%
SpS5.88
BVpS3.45
TBVpS-3.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.57%
ROE -225.49%
ROCE 1.79%
ROIC 1.41%
ROICexc 1.86%
ROICexgc 7.88%
OM 3.57%
PM (TTM) N/A
GM 70.24%
FCFM 14.85%
ROA(3y)-37.21%
ROA(5y)-22.01%
ROE(3y)-156.16%
ROE(5y)-93.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y38.84%
ROICexcg growth 5Y29.35%
ROICexc growth 3Y39.52%
ROICexc growth 5Y37.04%
OM growth 3Y-6.27%
OM growth 5Y3.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y1.84%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.83
Debt/EBITDA 9.82
Cap/Depr 53.66%
Cap/Sales 2.33%
Interest Coverage 1.51
Cash Conversion 217.18%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.46
Altman-Z -0.95
F-Score3
WACC8.62%
ROIC/WACC0.16
Cap/Depr(3y)50.56%
Cap/Depr(5y)51.08%
Cap/Sales(3y)2.85%
Cap/Sales(5y)3.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.89%
EPS 3Y-23.41%
EPS 5YN/A
EPS Q2Q%733.33%
EPS Next Y-69.13%
EPS Next 2Y-44.6%
EPS Next 3Y-29.21%
EPS Next 5Y26.55%
Revenue 1Y (TTM)-27.06%
Revenue growth 3Y-5.05%
Revenue growth 5Y1.79%
Sales Q2Q%15.02%
Revenue Next Year-25.61%
Revenue Next 2Y-10.65%
Revenue Next 3Y-4.8%
Revenue Next 5YN/A
EBIT growth 1Y-81.46%
EBIT growth 3Y-11%
EBIT growth 5Y5.05%
EBIT Next Year-43.25%
EBIT Next 3Y-3.74%
EBIT Next 5Y31.94%
FCF growth 1Y371.68%
FCF growth 3Y-41.96%
FCF growth 5Y-31.95%
OCF growth 1Y1092.89%
OCF growth 3Y-38.63%
OCF growth 5Y-27.87%